Acquisition provides GfK’s health care clients with a high level of strategic support across increasingly complex areas of pricing, reimbursement…
Bridgehead International has recently completed a substantial commercial due diligence assignment for The Riverside Company. The target was a European pharmaceutical company with both marketed assets and a strong R&D pipeline.
Bridgehead International provides due diligence for Investinor AS, lead investor in BerGenBio AS, a norwegian oncology company
